Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|September 21, 2022
Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection FractionMasami Nishino, Yasuyuki Egami, Shodai Kawanami, et al.
ESC Heart Failure|May 2, 2021
High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fractionMasamichi Yano, Masami Nishino, Kohei Ukita, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2026
Apple Watch-Guided Anticoagulation After Atrial Fibrillation Ablation - The Up to AF TrialAkihiro Sunaga, Nobuaki Tanaka, Yasuyuki Egami, et al.
ESC Heart Failure|March 10, 2021
Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registryMasami Nishino, Masamichi Yano, Kohei Ukita, et al.
International Heart Journal|September 21, 2021
Underweight Is Associated with Poor Prognosis in Heart Failure with Preserved Ejection FractionYutaka Matsuhiro, Masami Nishino, Kohei Ukita, et al.
ESC Heart Failure|June 30, 2021
Impact of admission hyperglycaemia on clinical outcomes in non-diabetic heart failure with preserved ejection fractionMasamichi Yano, Masami Nishino, Kohei Ukita, et al.
European Journal of Heart Failure|March 11, 2026
Are β-Blockers Necessary for Patients with Heart Failure with Preserved Ejection Fraction? : PurSuit-HFpEF RegistryMasami Nishino, Yasuyuki Egami, Taichi Mukai, et al.
Nutrients|October 27, 2022
Change in Nutritional Status during Hospitalization and Prognosis in Patients with Heart Failure with Preserved Ejection FractionAkihiro Sunaga, Shungo Hikoso, Takahisa Yamada, et al.
Heart and Vessels|April 15, 2025
Characteristics of comparatively young heart failure with preserved ejection fraction: PurSuit-HFpEF registryMasami Nishino, Yasuyuki Egami, Ayako Sugino, et al.
Heart Rhythm|February 2, 2024
Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablationYasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, et al.
Pageof 22